Indatraline
Jump to navigation
Jump to search
| File:Indatraline.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C16H15Cl2N |
| Molar mass | 292.202 g/mol |
Indatraline, also known as Lu 19-005, is a nonselective monoamine reuptake inhibitor that has been shown to block the reuptake of dopamine, norepinephrine, and serotonin with effects similar to those of cocaine. However, the effects have been shown to have slower onset and longer duration than cocaine, suggesting that the compound may, along with similar compounds, be used for treatment of cocaine abuse.[1]
For a more detailed discussion of indatraline pharmacology, see Indatraline pharmacology
References
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Addiction
- Stimulants
- Dopamine reuptake inhibitors